期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
探讨孕激素治疗无排卵型月经不调的应用 被引量:5
1
作者 李翠菊 《中外医疗》 2020年第18期38-40,共3页
目的探讨孕激素治疗无排卵型月经不调的应用效果。方法便利抽取该院2018年6月—2019年6月间接收的无排卵型月经不调患者184例,随机将其分为小剂量组(服用孕激素药物100 mg/d)与大剂量组(服用孕激素药物300 mg/d),每组均为92例,治疗结束... 目的探讨孕激素治疗无排卵型月经不调的应用效果。方法便利抽取该院2018年6月—2019年6月间接收的无排卵型月经不调患者184例,随机将其分为小剂量组(服用孕激素药物100 mg/d)与大剂量组(服用孕激素药物300 mg/d),每组均为92例,治疗结束对两组患者的治疗效果进行比较。结果两组患者的子宫内膜厚度、月经量、月经持续时间分别为(6.34±0.27)、(6.41±0.23)mm和(87.44±6.48)、(86.57±7.11)mL以及(5.54±1.48)、(5.57±1.11)d,均差异无统计学意义(t=1.893、0.867、0.156,P=0.060、0.387、0.877>0.05),小剂量组服药后不良反应率为7.61%(7/92),低于大剂量组患者36.96%(34/92),差异有统计学意义(χ^2=22.878,P=0.000<0.05)。结论在对无排卵型月经不调患者进行治疗和调理期间,采用小剂量的孕激素药物的治疗效果与大剂量孕激素药物治疗效果相差较小,但不良反应较轻。 展开更多
关键词 不同剂量孕激素 无排卵型月经不调 宫内膜厚度 月经 月经持续时间 不良反应率
下载PDF
Effectiveness of external Sanjierupi Gao on mastalgia caused by mammary gland hyperplasia: a placebo controlled trial 被引量:8
2
作者 Yingyi Fan Xiaohua Pei +4 位作者 Zhaolan Liu Zhongyuan Xia Dongxiao Zhang Afeng Song Duo Liu 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2013年第5期603-607,共5页
OBJECTIVE:To evaluate the curative effect of external application of the Chinese drug,Sanjierupi Gao,on mastalgia caused by mammary gland hyperplasia.METHODS:This randomized,double-blinded,and placebo controlled study... OBJECTIVE:To evaluate the curative effect of external application of the Chinese drug,Sanjierupi Gao,on mastalgia caused by mammary gland hyperplasia.METHODS:This randomized,double-blinded,and placebo controlled study enrolled 260 patients with mammary gland hyperplasia from five hospitals.Patients were randomly and equally divided in-to a Sanjierupi Gao treatment group and a placebo control group.An adhesive plaster was applied to the most painful area on either breast for 7 h a day.Treatment lasted for two menstrual cycles without application during menstruation.Mastalgia was used as the main index of curative effect.The change before and after treatment in days of mastalgia,the time to alleviate pain,pain extent,and severe pain scores were observed.RESULTS:Compared to the control group,the treatment group had significantly fewer days of mastalgia(P<0.01),a significantly lower severe pain score(P<0.01),and significantly less subjective pain and tenderness(P<0.05 and P<0.01,respectively).Three days before the follow-up visit,the pain score in the treatment group was significantly lower than that in the control group(P<0.05).A non-parametric test was used to compare the time to alleviate mastalgia between the two groups and found no statistical difference(Z=0.313,P=0.754).CONCLUSION:Application of Sanjierupi Gao can decrease mastalgia duration in patients with mammary gland hyperplasia during menstruation and alleviate the extent of mastalgia.The time to alleviate pain is psychologically influenced. 展开更多
关键词 Fibrocystic disease of breast Pain Treatment outcome Application therapy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部